Treatment
Standard care clinical trials
We’re tracking 1,103 recruiting studies that include Standard care, each written for real people, not researchers, below.
Recruiting studies
- NCT06401980RecruitingPhase 2
Darolutamide for advanced prostate cancer that has stopped responding to hormone therapy
This trial tests the drug darolutamide for men whose prostate cancer has spread and is no longer controlled by standard hormone therapy. It may be an option if you've already had certain hormone treatments for at least 12 months but your cancer is still progressing.
AarauAges 18 years+ - NCT06406621Recruiting
Laser hair removal to prevent pilonidal disease in darker skin
This study tests whether laser hair removal can help prevent pilonidal disease from coming back in people with darker skin. It is designed for teenagers and young adults who have had pilonidal disease but are not currently having a flare-up.
Wilmington, DelawareAges 10–21 - NCT06388590Recruiting
Acupuncture for chronic pelvic pain
This trial tests whether acupuncture can help relieve long-term pelvic pain. It is for women who are part of the military community and have not had endometriosis found during a laparoscopy.
Nellis Air Force Base, NevadaAges 21–65 - NCT06389240Enrolling by invitation
Early weight bearing for shinbone fractures
This study tests whether starting to put weight on your leg early after surgery helps people with a certain type of shinbone fracture heal better. If you qualify, you'll receive standard surgery and then be assigned to either an early or a delayed weight bearing schedule.
Salt Lake City, UtahAges 18–65 - NCT06367257Recruiting
App to improve nutrition during head and neck cancer radiation
This study tests whether a smartphone app (Emento) can help people with head and neck cancer track and improve their nutrition during and after radiation therapy. The goal is to see if using the app makes it easier to eat well and stay healthy during treatment.
Erlangen, BavariaAges 18 years+ - NCT06368388Recruiting
Personalized phage therapy for hard-to-treat infections
This trial studies using phages (viruses that attack bacteria) to treat infections that have not improved with other treatments. It aims to see if this patient-specific approach works and what it costs.
LeuvenAges Any age - NCT06370481Recruiting
HIV and addiction training program for Alabama clinics
This study tests a program to help people living with HIV in Alabama who also struggle with opioid or stimulant use. It takes place at your HIV clinic and checks whether a new approach to addiction care can improve your health.
Birmingham, AlabamaAges 18 years+ - NCT06326190RecruitingPhase 2
Study of radioactive drug for recurrent meningioma
This trial tests a radioactive drug called 177Lu-DOTATATE for people with recurrent meningioma (a type of brain tumor) that has grown after surgery and radiation. The drug targets a protein on the tumor cells and delivers radiation directly to them.
InnsbruckAges 18 years+ - NCT05794958RecruitingPhase 1
Safety of second CAR-T re-infusion for hard-to-treat lymphoma
This Phase 1 study tests whether a second re-infusion of axicabtagene ciloleucel (CAR-T) is safe in people with aggressive B-cell non-Hodgkin lymphoma that came back or did not respond after standard second-line CAR-T. It may help some patients by trying to improve disease control while carefully monitoring side effects.
Palo Alto, CaliforniaAges 18 years+ - NCT06337097Recruiting
Monitoring heart enzyme during immunotherapy
This study is for people starting immunotherapy with checkpoint inhibitors. It checks a heart enzyme (troponin) to see if the treatment affects your heart, so your doctor can monitor and manage any changes early.
Houston, TexasAges 18 years+ - NCT06319248RecruitingPhase 2
Midodrine to treat sepsis and reduce IV vasopressors
This trial tests if the oral medication midodrine can help wean patients with sepsis off IV vasopressors faster, potentially reducing ICU stays and complications.
Scottsdale, ArizonaAges 18 years+ - NCT06327061Recruiting
Opioid overdose prevention with friends and family
This trial tests a program where people who use opioids learn to educate their friends and family about overdose prevention. It may help build a safer support network in Baltimore.
Baltimore, MarylandAges 18 years+ - NCT06335719Recruiting
Electrical stimulation during nerve grafting for facial paralysis
This trial tests whether using gentle electrical stimulation during surgery can improve the results of nerve grafting for people with facial paralysis on one side. It's for patients who are already planning a two-stage surgery to restore their smile.
Cleveland, OhioAges 18–80 - NCT06311578RecruitingPhase 1
Study of JNJ-87704916 alone or with other drugs for advanced solid tumors
This trial tests a new drug, JNJ-87704916, given alone or with other treatments for people with advanced solid tumors that have stopped responding to standard therapies. It may be an option if you have a tumor that can be injected and are in good overall health.
New York, New YorkAges 18 years+ - NCT06306300RecruitingPhase 4
Hepatitis C treatment at local clinics vs standard care
This study compares two ways to treat hepatitis C: getting treatment at a local clinic near you, or the usual care at a central hospital. It aims to see if treatment at local clinics is safe, effective, and more convenient for patients.
Rio de Janeiro, Rio de JaneiroAges 18–79 - NCT06298721Recruiting
Personalized care to improve knee replacement satisfaction
This study tests a personalized approach to knee replacement surgery designed for people who are at higher risk of being dissatisfied after the procedure. The goal is to see if tailoring care based on patient-reported outcomes can improve satisfaction.
Cleveland, OhioAges 18–80 - NCT06293469Recruiting
Speeding up flap surgery for severe leg injuries
This trial tests whether performing flap surgery sooner after a severe leg injury below the knee leads to better outcomes. If you have an open fracture or dislocation that needs a flap, you may be able to join.
Sacramento, CaliforniaAges 18 years+ - NCT06275919RecruitingPhase 2
Regorafenib for recurring meningioma
This trial tests a pill called regorafenib for people whose meningioma (a brain tumor) has come back and cannot be treated with surgery or radiation. The goal is to see if regorafenib can help stop the tumor from growing further.
Meldola, Forlì-CesenaAges 18 years+ - NCT06267482Recruiting
Robotic knee replacement for better outcomes
This study tests a robot-assisted tool for knee replacement surgery. It aims to make surgery more precise and improve recovery and comfort for people with knee osteoarthritis.
London, OntarioAges 21–80 - NCT06263712Recruiting
Can brief therapy after a suicide attempt help?
This study tests whether a short therapy program (ASSIP) can help reduce suicide risk by looking at how people think and feel after a suicide attempt. It may be a good fit if you've had a past attempt and are open to a brief, focused therapy.
BernAges 18 years+ - NCT06261398Recruiting
Better pregnancy outcomes with text support
This trial uses text messages and education to help improve pregnancy outcomes for women who are less than 21 weeks pregnant. It's designed for patients receiving care at certain Ohio State University clinics.
Columbus, OhioAges 18 years+ - NCT06255990Recruiting
Study of a new skin substitute for deep wounds
This study tests a new skin substitute called NovoSorb BTM for treating deep wounds that need a skin graft. If you have a large, full-thickness wound from an injury or reconstructive surgery, this trial may be an option to help your skin heal better.
Aarau, Canton of AargauAges 1–75 - NCT06263231RecruitingPhase 3
Study of INT230-6 injection for soft tissue sarcoma
This study tests an experimental drug, INT230-6, injected directly into tumors, compared to the usual treatments for soft tissue sarcoma. It aims to see if the injection is safe and works better for people whose cancer has not responded to earlier treatments.
Los Angeles, CaliforniaAges 18 years+ - NCT06247085RecruitingPhase 3
A study testing pegtibatinase for classical homocystinuria
This trial tests an injectable drug called pegtibatinase for people with a rare condition called homocystinuria. It aims to lower high levels of homocysteine in the blood compared to a placebo, while you continue your usual treatments.
Phoenix, ArizonaAges 12–65
Common questions
- Are there clinical trials studying Standard care?
- Yes. Clin2 currently lists 1,103 recruiting studies that include Standard care, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Standard care trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Standard care an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Standard care or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.